Company’s novel protocol offers cost-effective, reliable solution to create tissue blocks from laboratory-replicated fine needle aspirations (FNAs) WESTBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global ...
With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results